（文章来源：每日经济新闻） 每经AI快讯，8月12日，中药概念持续走强，莱茵生物涨停，众生药业、康缘药业、京新药业、振东制 药、康恩贝、红日药业等跟涨。 ...

截至2025年8月8日 10:49，中证中药指数(930641)上涨0.48%，成分股众生药业(002317)上涨6.44%，亚 宝药业(600351)上涨3.74%，千金药业(600479)上涨2.59%，方盛制药(603998)上涨1.49%，红日药业 (300026)上涨1.45%。中药ETF(159647)上涨0.49%，最新价报1.04元。 8月5日到7日，中药板块持续进行调整，但获资金逆市买入。中药ETF近3天获得连续资金净流入，最高 单日获得980.70万元净流入，合计"吸金"2020.76万元，日均净流入达673.59万元。 消息面上，中药饮片标签新规落地，江海证券指出，新规的实施使得中药饮片生产企业需要投入更多资 源用于确定保质期的研究工作。这增加了中小企业的成本负担，因为它们可能缺乏相应的科研能力与资 金实力。而头部企业凭借自身强大的研发团队、完善的质量控制体系以及充足的资金，能够更好地适应 这一要求。此前由于部分中药饮片未标注保质期，市场上存在一些以次充好、产品质量参差不齐的现 象。随着保质期标注的强制实施，一些无法满足合规要求的小作坊式企业将逐渐被市场淘汰，从而净化 市场环境。头部企业 ...

Market Overview - A-shares experienced narrow fluctuations in the morning session, with the three major indices showing slight increases. The Shanghai and Shenzhen markets had a half-day trading volume of 1.06 trillion, an increase of 52.5 billion compared to the previous trading day. The Shanghai Composite Index closed at 3627.54 points [1]. Sector Performance - The PEEK materials concept stocks continued to surge, with Zhongxin Fluorine Materials achieving two consecutive trading limits. Military stocks also saw significant gains, with Great Wall Military Industry hitting four trading limits in five days. Liquid cooling server concept stocks rose sharply, with Kexin Innovation Source reaching a 20% trading limit. Conversely, pharmaceutical stocks underwent adjustments, with companies like Hanyu Pharmaceutical seeing declines of over 5% [3]. - The sectors with the highest gains included PEEK materials, military, liquid cooling servers, and humanoid robots, while the sectors with the largest declines included traditional Chinese medicine, Tibet-related stocks, innovative pharmaceuticals, and film and television [3]. - By the end of the session, the Shanghai Composite Index rose by 0.27%, the Shenzhen Component Index increased by 0.46%, and the ChiNext Index gained 0.39% [3].

连板股方面，*ST亚太（维权）7天4板，宏和科技、天府文旅等5天3板，*ST亚振、胜通能源3连板，福 元医药4天2板，中马传动3天2板，淳中科技、昂利康等2连板，深桑达Ａ、ST盛屯（维权）等涨停。 华瓷股份、保利联合（维权）连续2日跌停，*ST苏吴（维权）、大连友谊等跌停。 8月1日，A股全天下来共有49只涨停股、9只跌停股。中药概念活跃，奇正藏药3连板，贵州百灵（维 权）2连板，华森制药、太龙药业等涨停；智慧停车概念走强，东杰智能涨停。 ...

Group 1 - The Chinese herbal medicine index (930641) rose by 0.99% as of May 20, 2025, with notable increases in stocks such as Zhaoli Pharmaceutical (300181) up 3.52% and Jinghua Pharmaceutical (002349) up 3.16% [1] - The Chinese herbal medicine ETF (159647) increased by 1.03%, with a recent price of 0.98 yuan, and has seen a cumulative increase of 1.25% over the past week [1] - The upcoming 618 shopping festival has led to strong performance in traditional Chinese medicine health products on platforms like Tmall, with brands such as Xiaoxian Stew and Yanzhi House ranking high in sales [1] Group 2 - Since 2022, the health supplement industry on Douyin has experienced steady growth, with a projected monthly sales volume exceeding 30 million units by 2024, and over 300 million users engaging with health supplement products [2] - A joint initiative by 12 government departments aims to promote health consumption, which includes traditional Chinese medicine, thereby enhancing market demand and consumer willingness to purchase related products [2] - Analysts predict that the Chinese medicine sector will see a performance turning point in Q2 2025, with potential early market activity, supported by expanding insurance coverage and the need for companies to improve efficiency through modernization [2] Group 3 - The Chinese herbal medicine ETF closely tracks the Chinese herbal medicine index, which includes publicly listed companies involved in the production and sale of traditional Chinese medicine [3] - As of April 30, 2025, the top ten weighted stocks in the Chinese herbal medicine index accounted for 55.71% of the index, with major companies including Yunnan Baiyao (000538) and Tongrentang (600085) [3]